Oral Manifestation of COVID 19 Patient: A Cross Sectional Study on Egyptian Population

July 15, 2020 updated by: Dina mounir elkady, Cairo University

Oral Manifestation of COVID19

The oral manifestation of COVID 19 that could help in the diagnosis of patient

Study Overview

Status

Unknown

Conditions

Detailed Description

Oral ulceration,oral lesion,sensitivity that has been reported by patient tested positive for COVID 19

Study Type

Observational

Enrollment (Anticipated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Cairo, Egypt, 2346
        • Recruiting
        • Cairo University
        • Contact:
          • Dina Mounir Elkady, Phd
          • Phone Number: 01004297317
        • Contact:
          • Rawda Hesham Abdel aziz, Phd

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Egyptian population tested COVID positive either hospitalized or not

Description

Inclusion Criteria:

  • Tested COVID positive
  • No other chronic disease that has oral manifestation
  • Above 18

Exclusion Criteria:

  • Children
  • Patient with no COVID positive

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oral manifestation
Time Frame: 1month
The presence or absence or oral manifestation like ulcer burning sensation..will be measured by yes or no using a list of question
1month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cairo University

Investigators

  • Principal Investigator: Dina Mounir Elkady, Lecturer at cairo ubiversity

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 30, 2020

Primary Completion (Anticipated)

August 30, 2020

Study Completion (Anticipated)

August 30, 2020

Study Registration Dates

First Submitted

May 14, 2020

First Submitted That Met QC Criteria

May 15, 2020

First Posted (Actual)

May 18, 2020

Study Record Updates

Last Update Posted (Actual)

July 16, 2020

Last Update Submitted That Met QC Criteria

July 15, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 54678

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Oral Health and COVID 19

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe